IL324263A - ננו-תרחיפים של קורטיקוסטרואידים ושימושים בהם - Google Patents
ננו-תרחיפים של קורטיקוסטרואידים ושימושים בהםInfo
- Publication number
- IL324263A IL324263A IL324263A IL32426325A IL324263A IL 324263 A IL324263 A IL 324263A IL 324263 A IL324263 A IL 324263A IL 32426325 A IL32426325 A IL 32426325A IL 324263 A IL324263 A IL 324263A
- Authority
- IL
- Israel
- Prior art keywords
- clobetasol propionate
- nanoparticles
- injection
- formulation
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Otolaryngology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363463113P | 2023-05-01 | 2023-05-01 | |
| PCT/US2024/026982 WO2024228993A2 (en) | 2023-05-01 | 2024-04-30 | Corticosteroid nanosuspensions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324263A true IL324263A (he) | 2025-12-01 |
Family
ID=93333275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324263A IL324263A (he) | 2023-05-01 | 2025-10-27 | ננו-תרחיפים של קורטיקוסטרואידים ושימושים בהם |
Country Status (8)
| Country | Link |
|---|---|
| KR (1) | KR20260005253A (he) |
| CN (1) | CN121038796A (he) |
| AU (1) | AU2024265712A1 (he) |
| CO (1) | CO2025015291A2 (he) |
| IL (1) | IL324263A (he) |
| MX (1) | MX2025013065A (he) |
| TW (1) | TW202448423A (he) |
| WO (1) | WO2024228993A2 (he) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI773641B (zh) * | 2015-05-08 | 2022-08-11 | 日商活效製藥股份有限公司 | 含有糖皮質類固醇(glucocorticoids)之奈米微粒子之水性懸浮液劑 |
| AU2018288256B2 (en) * | 2017-06-23 | 2023-09-28 | Laboratorios Salvat, S.A. | An oil-in-water nanoemulsion composition of clobetasol |
-
2024
- 2024-04-30 WO PCT/US2024/026982 patent/WO2024228993A2/en active Pending
- 2024-04-30 TW TW113116200A patent/TW202448423A/zh unknown
- 2024-04-30 KR KR1020257036363A patent/KR20260005253A/ko active Pending
- 2024-04-30 AU AU2024265712A patent/AU2024265712A1/en active Pending
- 2024-04-30 CN CN202480029391.1A patent/CN121038796A/zh active Pending
-
2025
- 2025-10-27 IL IL324263A patent/IL324263A/he unknown
- 2025-10-31 CO CONC2025/0015291A patent/CO2025015291A2/es unknown
- 2025-10-31 MX MX2025013065A patent/MX2025013065A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO2025015291A2 (es) | 2025-11-19 |
| KR20260005253A (ko) | 2026-01-09 |
| WO2024228993A2 (en) | 2024-11-07 |
| MX2025013065A (es) | 2025-12-01 |
| AU2024265712A1 (en) | 2025-11-13 |
| TW202448423A (zh) | 2024-12-16 |
| WO2024228993A3 (en) | 2025-03-20 |
| CN121038796A (zh) | 2025-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10918594B2 (en) | Controlled-release CNS modulating compositions and methods for the treatment of otic disorders | |
| US20250381215A1 (en) | High elasticity hyaluronan compositions and methods of use thereof | |
| CA2723458C (en) | Controlled release corticosteroid compositions and methods for the treatment of otic disorders | |
| JP6209777B2 (ja) | 眼の疾病及び疾患のための組成物及び治療 | |
| Chang et al. | Phase II results of an intraocular steroid delivery system for cataract surgery | |
| JPH09510961A (ja) | 持続性および長期間の角膜鎮痛の方法 | |
| US20090123527A1 (en) | Method of inducing topical anesthesia and transdermal patch | |
| KR20160047490A (ko) | 소아 귀 질환의 치료 | |
| Sarchahi et al. | Effect of four local anesthetics (tetracaine, proparacaine, lidocaine, and bupivacaine) on intraocular pressure in dogs | |
| TW202515576A (zh) | 治療眼表痛之方法 | |
| AU2024265712A1 (en) | Corticosteroid nanosuspensions and uses thereof | |
| EP2424535B1 (en) | Methods and compositions for treating dry eye | |
| WO2011049954A2 (en) | Compositions comprising wnt modulators or neurotoxins for the treatment of otic disorders | |
| JP6453318B2 (ja) | 委縮性皮膚瘢痕を治療するためのプロスタグランジンF2α及びその類似体 | |
| CN107137698A (zh) | 一种包含gdnf的用于治疗角膜上皮损伤的药物组合物 | |
| Richa et al. | Promising implication of ocuserts in ocular disease | |
| EA002267B1 (ru) | Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат | |
| EP4442269A1 (en) | Novel use of alanyl-glutamine and ophthalmic composition comprising alanyl-glutamine | |
| TWI632913B (zh) | 用於眼部疾病或異常之組合物及其治療方法 | |
| WO2022140636A1 (en) | Gacyclidine otic formulations and uses thereof | |
| Gilger | Navigating the myths and folktales of ocular medication-treatment of corneal and ocular surface diseases. | |
| WO2016104705A1 (ja) | 眼の自覚症状を改善する剤および方法 |